ETFinnovators (< 20)

Teva is on Target to Acquire Barr

October 29, 2008 – Comments (0) | RELATED TICKERS: TEVA , BRL.DL , JNJ

Teva is on Target to Acquire Barr

[web link to updated calendar of over 70 pending FDA dates]

The accompanying table [click to enlarge image] presents an updated calendar of expected FDA decision dates, including a new NDA filing by Johnson & Johnson (JNJ) for Comfyde and recent approval for Barr Pharma's (BRL) low-dose birth control pill Lo-Seasonique. Teva Pharma (TEVA) has closed a deal with Barr's unsecured credit holders in an effort to close its proposed $7.5B acquisition by year-end, which will expand Teva's generic drug business and also add to its line-up of brand name medications through Barr's strong presence in birth control.